{"title": "Janssen Oncology Data to be Presented at 2013 American Society of Hematology (ASH) Annual Meeting", "author": "Carly Helfand", "url": "https://www.fiercepharma.com/pharma/janssen-oncology-data-to-be-presented-at-2013-american-society-of-hematology-ash-annual", "hostname": "fiercepharma.com", "description": "Janssen Oncology Data to be Presented at 2013 American Society of Hematology (ASH) Annual Meeting Findings Highlight Company's Growing Hematologic Area of Focus, including Ibrutinib, Siltuximab,... | Janssen Oncology Data to be Presented at 2013 American Society of Hematology (ASH) Annual Meeting Findings Highlight Company's Growing Hematologic Area of Focus, including Ibrutinib, Siltuximab,...", "sitename": "FiercePharma", "date": "2013-12-09", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}